Article
Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
Arthritis and rheumatism - 1 Dec 2009
Okada Yukinori, Yamada Ryo, Suzuki Akari, Kochi Yuta, Shimane Kenichi, Myouzen Keiko, Kubo Michiaki, Nakamura Yusuke, Yamamoto Kazuhiko
Abstract excerpt
OBJECTIVE: To examine the risk of anti-cyclic citrullinated peptide (anti-CCP) antibody positivity in rheumatoid arthritis (RA) patients carrying certain haplotypes in the HLA region. METHODS: A total of 1,389 Japanese patients with RA were genotyped for 30 single-nucleotide polymorphisms (SNPs) in the HLA region using commercial oligonucleotide arrays (from Perlegen or Affymetrix) as well as for HLA-DRB1 alleles...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
